Free Trial

ADC Therapeutics (ADCT) SEC Filings & 10K Form

ADC Therapeutics logo
$1.96 -0.16 (-7.55%)
(As of 05:31 PM ET)

Recent ADC Therapeutics SEC Filings

DateFilerForm TypeView
12/13/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:37 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:39 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:42 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:35 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:30 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/13/2024
3:13 PM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
7:58 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/13/2024
7:30 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/07/2024
9:44 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:54 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:35 PM
ADC Therapeutics (Filer)
Form DEF 14A
09/23/2024
3:39 PM
ADC Therapeutics (Filer)
Form DEFA14A
08/13/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
08/06/2024
3:26 PM
ADC Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
9:06 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:37 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
7:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:40 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:41 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:43 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:45 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:29 PM
ADC Therapeutics (Subject)
Azelby Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:30 PM
ADC Therapeutics (Subject)
Squarer Ron (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:35 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:37 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:38 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
ADC Therapeutics (Subject)
BIZZARI JEAN-PIERRE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:28 PM
ADC Therapeutics (Subject)
Sandor Victor (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:44 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:46 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:37 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:23 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:25 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:29 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
2:33 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2024
11:32 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:06 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

05/07/2024
3:06 PM
ADC Therapeutics (Subject)
MALLIK AMEET (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
5:51 AM
ADC Therapeutics (Filer)
Form 424B5
05/06/2024
5:38 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
5:29 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
8:31 PM
ADC Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
Form SC 13G
04/26/2024
3:21 PM
ADC Therapeutics (Filer)
Form DEFA14A
04/16/2024
3:16 PM
ADC Therapeutics (Filer)
Form PRE 14A
04/09/2024
3:06 PM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:11 PM
ADC Therapeutics (Filer)
Form 424B3
03/15/2024
3:11 PM
ADC Therapeutics (Filer)
Form 424B3
03/14/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
03/14/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
03/14/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
03/13/2024
3:17 PM
ADC Therapeutics (Filer)
Form POS AM
03/13/2024
3:14 PM
ADC Therapeutics (Filer)
Form POS AM
03/13/2024
2:19 PM
ADC Therapeutics (Filer)
Form ARS
03/13/2024
11:25 AM
ADC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
6:39 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
8:15 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
8:47 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
02/12/2024
9:13 AM
ADC Therapeutics (Subject)
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Form SC 13G/A
02/09/2024
8:50 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
8:45 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2024
7:00 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:30 PM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:15 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:00 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
7:00 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:01 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:02 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:04 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:05 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:06 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:07 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:08 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:09 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:10 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
6:56 PM
ADC Therapeutics (Issuer)
Rivers Tyrell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
6:58 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
6:59 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ADCT) was last updated on 12/20/2024 by MarketBeat.com Staff
From Our Partners